Development of Pasteurella multocida-loaded microparticles for hemorrhagic septicemia vaccine

被引:8
作者
Nimtrakul, Pataranapa [1 ,2 ]
Atthi, Ratchanee [3 ]
Limpeanchob, Nanteetip [4 ]
Tiyaboonchai, Waree [1 ,2 ]
机构
[1] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Phitsanulok 65000, Thailand
[2] Commiss Higher Educ, Ctr Excellence Innovat Chem, Bangkok, Thailand
[3] Bur Vet Biol, Dept Livestock Dev, Pakchong, Nakhonratchasim, Thailand
[4] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok 65000, Thailand
关键词
Alginate; hemorrhagic septicemia; microparticles; Pasteurella multocida; vaccine; ORAL VACCINATION; IMMUNE-RESPONSE; PARTICULATE VACCINES; PARTICLE-SIZE; IN-SITU; ALGINATE; MICROSPHERES; CALVES; PROTECTION; PATHOGEN;
D O I
10.3109/03639045.2013.873448
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, Pasteurella multocida-loaded alginate microparticles (MPs) for subcutaneous vaccination was developed by emulsification-cross-linking technique. Formulation parameter was varied as a ratio of polymer and bacterin. Optical microscopy revealed spherical particles with uniformly distribution. A mean particle size of approximately 6 mm has been successfully constructed using simple mixer and ultrasonic probe. The zeta potential of the MPs showed negatively charge of approximately -23mV determined by Zeta Pals (R) analyzer. The entrapment efficiency and the in vitro bacterin released profile could be controlled by varying the amount of alginate. The high entrapment efficiency up to 69% was achieved with low concentration of alginate. The MPs possessed a slow bacterin release profile, up to 30 days. In vivo safety and potency tests were proved that the alginate MPs were safe and induced protective immunity in mice. In addition, after storage for 6 months at either 4 degrees C or room temperature, the protective immunity in mice was maintained.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 33 条
  • [1] Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery
    Alipour, Shohreh
    Montaseri, Hashem
    Tafaghodi, Mohsen
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2010, 81 (02) : 521 - 529
  • [2] ASEAN, 1998, ASEAN LIV PUBL A, V2A, P77
  • [3] Adjuvants designed for veterinary and human vaccines
    Aucouturier, J
    Dupuis, L
    Ganne, V
    [J]. VACCINE, 2001, 19 (17-19) : 2666 - 2672
  • [4] Oral vaccination with alginate microsphere systems
    Bowersock, TL
    HogenEsch, H
    Suckow, M
    Porter, RE
    Jackson, R
    Park, H
    Park, K
    [J]. JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) : 209 - 220
  • [5] Characterization of biologically active insulin-loaded alginate microparticles prepared by spray drying
    Bowey, Kristen
    Swift, Brenna E.
    Flynn, Lauren E.
    Neufeld, Ronald J.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (03) : 457 - 465
  • [6] Release of a macromolecular drug from alginate-impregnated microspheres
    Chretien, C
    Chaumeil, JC
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 304 (1-2) : 18 - 28
  • [7] Particulate vaccines: on the quest for optimal delivery and immune response
    De Temmerman, Marie-Luce
    Rejman, Joanna
    Demeester, Jo
    Irvine, Darrell J.
    Gander, Bruno
    De Smedt, Stefaan C.
    [J]. DRUG DISCOVERY TODAY, 2011, 16 (13-14) : 569 - 582
  • [8] Alginate-based microcapsules for immunoisolation of pancreatic islets
    de Vos, Paul
    Faas, Marijke M.
    Strand, Berit
    Calafiore, Ricardo
    [J]. BIOMATERIALS, 2006, 27 (32) : 5603 - 5617
  • [9] Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan
    El Maghraby, Gamal M.
    Elzayat, Ehab M.
    Alanazi, Fars K.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (08) : 971 - 978
  • [10] THE INVOLVEMENT OF CD14 IN STIMULATION OF CYTOKINE PRODUCTION BY URONIC-ACID POLYMERS
    ESPEVIK, T
    OTTERLEI, M
    SKJAKBRAEK, G
    RYAN, L
    WRIGHT, SD
    SUNDAN, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (01) : 255 - 261